The British In Vitro Diagnostic Association (BIVDA) has appointed Helen Dent as Chief Executive, following a successful period as Interim Chief Executive.
Helen will lead BIVDA in championing the medical diagnostics industry to politicians, policymakers, media and relevant stakeholders, and in supporting members to improve patient outcomes.
Her first act as Chief Executive was to launch BIVDA’s new strategy at the organisation’s annual general meeting. Helen, who previously spent over three years as Chief Operating Officer at BIVDA, brings over twenty years of industry experience to the business.
Prior to joining BIVDA, she worked at a senior level at Abbott Diagnostics in the UK and Europe. She has experience as National Contracts Manager at NHS Blood and Transplant, Pharmacy Buyer for Surrey and Sussex NHS Supply Management Confederation, and the NHS Purchasing and Supply Agency.
Helen said; “I’m thrilled to embark on this new role and lead BIVDA in shaping policy and delivering our new strategy at this crucial time for our members. It’s my priority to ensure members’ voices are not only heard, but also magnified to senior figures across the Government and NHS.”
